Prevalence of carbohydrate metabolism disorders in patients with end-stage renal disease on hemodialysis therapy

There are quite a lot of scientific works today dedicated to the role of disorders carbohydrate metabolism (DCM) in the development of end-stage renal disease (ESRD), at the same time, the influence of chronic kidney disease (CKD) on the development of carbohydrate disorders remains insufficiently s...

Full description

Bibliographic Details
Main Authors: T. N. Markova, V. O. Yavorskaya
Format: Article
Language:English
Published: Endocrinology Research Centre 2022-10-01
Series:Сахарный диабет
Subjects:
Online Access:https://www.dia-endojournals.ru/jour/article/view/12920
_version_ 1797255118208368640
author T. N. Markova
V. O. Yavorskaya
author_facet T. N. Markova
V. O. Yavorskaya
author_sort T. N. Markova
collection DOAJ
description There are quite a lot of scientific works today dedicated to the role of disorders carbohydrate metabolism (DCM) in the development of end-stage renal disease (ESRD), at the same time, the influence of chronic kidney disease (CKD) on the development of carbohydrate disorders remains insufficiently studied, especially in patients on renal replacement therapy (RRT). The annual steady increase in the number of patients with ESRD without diabetes mellitus (DM) requiring dialysis therapy leads to increased interest and the need to study carbohydrate status in these patients. It is known that hyperglycemia in patients without DM on hemodialysis (HD) is a predisposing factor to the development of cardiovascular accidents that worsen the quality of life and also increase mortality. The peculiarities of glucose metabolism in patients receiving RRT do not always allow adequate assessment of carbohydrate status using glycated hemoglobin (HbA1c). The review provides up-to-date information on the prevalence of DCM in patients with ESRD without DM receiving HD RRT, touches upon the peculiarities of glucose metabolism, interpretation of HbA1c and glycated albumin values, and mortality risk in hemodialysis patients with various DCM.
first_indexed 2024-03-08T15:18:55Z
format Article
id doaj.art-0ec68dc838b44836b7a0eebbd103a0b8
institution Directory Open Access Journal
issn 2072-0351
2072-0378
language English
last_indexed 2024-04-24T22:00:46Z
publishDate 2022-10-01
publisher Endocrinology Research Centre
record_format Article
series Сахарный диабет
spelling doaj.art-0ec68dc838b44836b7a0eebbd103a0b82024-03-20T11:48:04ZengEndocrinology Research CentreСахарный диабет2072-03512072-03782022-10-0125438839410.14341/DM1292010970Prevalence of carbohydrate metabolism disorders in patients with end-stage renal disease on hemodialysis therapyT. N. Markova0V. O. Yavorskaya1Moscow State University of Medicine and Dentistry named after A.I. Evdokimov; Moscow City Hospital 52Moscow State University of Medicine and Dentistry named after A.I. EvdokimovThere are quite a lot of scientific works today dedicated to the role of disorders carbohydrate metabolism (DCM) in the development of end-stage renal disease (ESRD), at the same time, the influence of chronic kidney disease (CKD) on the development of carbohydrate disorders remains insufficiently studied, especially in patients on renal replacement therapy (RRT). The annual steady increase in the number of patients with ESRD without diabetes mellitus (DM) requiring dialysis therapy leads to increased interest and the need to study carbohydrate status in these patients. It is known that hyperglycemia in patients without DM on hemodialysis (HD) is a predisposing factor to the development of cardiovascular accidents that worsen the quality of life and also increase mortality. The peculiarities of glucose metabolism in patients receiving RRT do not always allow adequate assessment of carbohydrate status using glycated hemoglobin (HbA1c). The review provides up-to-date information on the prevalence of DCM in patients with ESRD without DM receiving HD RRT, touches upon the peculiarities of glucose metabolism, interpretation of HbA1c and glycated albumin values, and mortality risk in hemodialysis patients with various DCM.https://www.dia-endojournals.ru/jour/article/view/12920renal replacement therapydisorders of carbohydrate metabolismchronic kidney diseasediabetes mellitusglycated albumin
spellingShingle T. N. Markova
V. O. Yavorskaya
Prevalence of carbohydrate metabolism disorders in patients with end-stage renal disease on hemodialysis therapy
Сахарный диабет
renal replacement therapy
disorders of carbohydrate metabolism
chronic kidney disease
diabetes mellitus
glycated albumin
title Prevalence of carbohydrate metabolism disorders in patients with end-stage renal disease on hemodialysis therapy
title_full Prevalence of carbohydrate metabolism disorders in patients with end-stage renal disease on hemodialysis therapy
title_fullStr Prevalence of carbohydrate metabolism disorders in patients with end-stage renal disease on hemodialysis therapy
title_full_unstemmed Prevalence of carbohydrate metabolism disorders in patients with end-stage renal disease on hemodialysis therapy
title_short Prevalence of carbohydrate metabolism disorders in patients with end-stage renal disease on hemodialysis therapy
title_sort prevalence of carbohydrate metabolism disorders in patients with end stage renal disease on hemodialysis therapy
topic renal replacement therapy
disorders of carbohydrate metabolism
chronic kidney disease
diabetes mellitus
glycated albumin
url https://www.dia-endojournals.ru/jour/article/view/12920
work_keys_str_mv AT tnmarkova prevalenceofcarbohydratemetabolismdisordersinpatientswithendstagerenaldiseaseonhemodialysistherapy
AT voyavorskaya prevalenceofcarbohydratemetabolismdisordersinpatientswithendstagerenaldiseaseonhemodialysistherapy